Morgan Stanley analyst Bob Huang lowered the firm’s price target on MetLife (MET) to $93 from $101 and keeps an Overweight rating on the shares. The firm is updating its price targets for Insurance – Life/Annuity North America stocks under its coverage, the analyst tells investors. While Morgan Stanley is not concerned about life insurers’ exposure to private credit, the broader industry will likely feel pressure on their valuation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife Issues $1 Billion Subordinated Debentures to Bolster Capital
- MetLife price target lowered to $93 from $97 at Wells Fargo
- MetLife Expands Board With Two New Independent Directors
- MetLife Announces First-Quarter 2026 Preferred Stock Dividends
- MetLife price target lowered to $100 from $102 at Mizuho